Pricing Log in Create free account

Gossamer Bio, Inc. (GOSS) vs Fractyl Health, Inc. (GUTS)

Gossamer Bio, Inc. and Fractyl Health, Inc. are both Biotechnology companies. Gossamer Bio, Inc. and Fractyl Health, Inc. are of similar size ($55.2M and $54.3M). Gossamer Bio, Inc. grew revenue faster over the last twelve months: 32.4% against −22.5%. Fractyl Health, Inc. has the higher net margin (0.00% vs −235.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Fractyl Health, Inc. leads on 9 and Gossamer Bio, Inc. on 6.

Valuation

Metric GOSS GUTS Biotechnology median
P/E n/m n/m 8.50
P/S 0.65 2,644.15 9.71
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 3.99 2,464.64 9.21
Earnings yield (526.56%) (56.77%) (33.15%)
Free cash flow yield (469.68%) (33.75%) (25.50%)

Profitability

Metric GOSS GUTS Biotechnology median
Gross margin 100.00% 46.24% 65.16%
Operating margin (311.70%) 0.00% 0.00%
Net margin (235.00%) 0.00% 0.00%
Free cash flow margin (305.19%) 0.00% 0.00%
Return on equity 178.72% 1,063.04% (56.36%)
Return on assets (78.81%) (146.75%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GOSS GUTS Biotechnology median
Revenue growth (TTM) 32.43% (22.50%) 6.02%
EPS growth (last fiscal year) (200.00%) (14.81%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric GOSS GUTS Biotechnology median
Debt to equity (0.38) (18.29) 0.00
Current ratio 0.53 3.15 4.72
Net debt to EBITDA (0.35) 0.53 0.96

Dividend

Metric GOSS GUTS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GOSS GUTS Biotechnology median
Market cap 54.32m 55.18m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack